Hikma Executive Chairman Pledges Shares
Company Announcements

Hikma Executive Chairman Pledges Shares

Hikma Pharmaceuticals (GB:HIK) has released an update.

Hikma Pharmaceuticals PLC has disclosed a financial transaction involving its Executive Chairman, Said Darwazah, who has pledged over 820,000 of his ordinary shares in favor of EFG Private Bank UK Limited. The transaction did not involve any exchange of funds and took place outside of trading venues on May 31, 2024. This move may interest shareholders and potential investors as it reflects managerial financial decisions within the company.

For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskHikma Pharmaceuticals Reappoints PwC as Auditor
TipRanks UK Auto-Generated NewsdeskHikma Pharmaceuticals Projects Strong Growth for 2024
TipRanks UK Auto-Generated NewsdeskHikma Pharmaceuticals Faces Shareholder Opposition on Buyback Waiver
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App